Cite

HARVARD Citation

    Brehm, H. et al. (2015). Targeted killing of rhabdomyosarcoma cells by a MAP-based human cytolytic fusion protein. Cancer letters. 365 (2), pp. 149-155. [Online]. 
  
Back to record